TRADING UPDATES: Equipmake hails "key milestone" for Project Coeus
(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News: Read More
| Price | 64.00p on 12-10-2026 at 17:25:07 |
|---|---|
| Change | -1.50p -2.29% |
| Buy | 65.00p |
| Sell | 63.00p |
| Last Trade: | Unknown 60,000.00 at 64.00p |
| Day's Volume: | 1,379,659 |
| Last Close: | 64.00p |
| Open: | 65.50p |
| ISIN: | GB00BYYW9G87 |
| Day's Range | 64.00p - 65.20p |
| 52wk Range: | 49.00p - 90.50p |
| Market Capitalisation: | £280.09m |
| VWAP: | 64.13769p |
| Shares in Issue: | 437.63m |
Sector: Medicine and Biotech
Listed In: FTSE AIM All-Share,
Avacta Group (AVCT) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Unknown* | 60,000 | 64.00p | OTC Trade |
17:07:30 - 12-Oct-26 |
| Sell* | 43,097 | 63.25p | Negotiated Trade |
16:35:08 - 12-Oct-26 |
| Sell* | 43,097 | 63.25p | Ordinary |
16:31:48 - 12-Oct-26 |
| Sell* | 1,249 | 63.73p | Ordinary |
16:30:00 - 12-Oct-26 |
| Sell* | 220 | 63.78p | Ordinary |
16:20:12 - 12-Oct-26 |
| Sell* | 43,097 | 63.25p | Negotiated Trade |
16:11:44 - 12-Oct-26 |
| Sell* | 60,000 | 63.275p | Ordinary |
16:11:02 - 12-Oct-26 |
| Sell* | 3,635 | 63.8968p | Ordinary |
16:05:34 - 12-Oct-26 |
| Sell* | 1,000 | 63.90p | Ordinary |
15:59:46 - 12-Oct-26 |
| Sell* | 700 | 63.6254p | Ordinary |
15:54:21 - 12-Oct-26 |
Avacta Group (AVCT) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 6th Oct 2026 7:30 am | RNS | Capital Access Window - Avacta Group Plc |
| 6th Oct 2026 7:00 am | RNS | Results of Placing and Subscription |
| 5th Oct 2026 4:22 pm | RNS | Proposed Fundraise to raise approximately £12.5m |
| 30th Sep 2026 7:30 am | RNS | Capital Access Window - Avacta Group Plc |
| 30th Sep 2026 7:01 am | RNS | Capital Access Window |
| 30th Sep 2026 7:00 am | RNS | Interim Results for Six Months to June 30, 2026 |
| 25th Sep 2026 8:00 am | RNS-R | pre|CISION® Platform Wins R&D Achievement Award |
| 25th Sep 2026 7:00 am | RNS | Further Demonstration of Potential of AVA6103 |
| 16th Sep 2026 7:00 am | RNS | Clinical Proof of Mechanism for preCISION Platform |
| 14th Sep 2026 7:00 am | RNS | Mats Blom to Board as Chair of Audit Committee |